Abstract: The invention relates to novel and valuable intermediate compounds of the general formula (VIII) which can be used for the preparation of novel compounds comprising an antibacterial action, especially with a strong antibacterial action against helicobacter pylori, and pharmaceutically acceptable salts thereof. In the general formula (VIII) X is hydrogen or halogen, Y is hydrogen or a substituted or unsubstituted aralkyloxycarbonyl group having 8-19 carbon atoms, Z is hydrogen, a substituted aralkyloxycarbonyl group having 8-19 carbon atoms or a substituted alkoxycarbonyyl group having 2-19 carbon atoms, except that X, Y and Z are all hydrogen.

Abstract: The present invention relates to a pharmaceutical composition which is appropriate for eradication or extermination of Helicobacter pylori wherein [4-[4-(4-methylbenzyloxycarbonyl)phenyl[phenyl trans-4-guanidinomethylcyclohexanecarboxylate or an acid addition salt thereof are compounded and it also relates to a complex consisting them.

Abstract: A compound represented by general formula (I-2) or a pharmaceutically acceptable acid-addition salt thereof, useful as an anti-microbial against Helicobacter pylori and as a medicinal composition for treating Helicobacter pylori infection, wherein Ar represents phenyl, biphenyl or naphthyl each having a at least one substituent selected from the group consisting of halogen, cyano, nitro, carboxy, C1-C18 alkyl, C1-C18 alkoxy, C3-C18 cycloalkyl, C7-C18 aralkyl, C8-C18 arylalkenyl, C7-C18 aralkyloxy, optionally substituted phenoxy, optionally substituted C2-C19 alkoxycarbonyl, and optionally substituted C8-C19 aralkyloxycarbonyl, provided the case where Ar represents phenyl substituted by halogen, cyano, nitro, carboxy, C1-C18 alkyl, optionally substituted C2-C19 alkoxycarbonyl or C8-C19 aralkyloxycarbonyl is expected.

Abstract: A chelating composition containing an aliphatic polycarboxylic acid of the following formula (I): ##STR1## wherein A is an imino group or an oxygen atom, R is a hydrogen atom or a hydroxyl group, and n is 0 or 1, or the salt thereof and sugar or saccharic acid of 4 to 12 carbon atoms at such a ratio as enables the components to manifest synergistic effects is provided. This chelating composition is capable of effectively sequestering a metal ion and preventing the metal ion from being insolubilized without causing pollution of the environment.

Abstract: A ferroelectric liquid crystal electro-optical device comprises a pair of plates having driving electrodes and ferroelectric liquid crystal material having a negative dielectric anisotropy. The ferroelectric liquid crystal material comprises a ferroelectric liquid crystal composition 10 to 80% by weight of a compound of the general formula: ##STR1## wherein R.sub.1 represents a straight-chain alkyl or alkoxy group, or an alkyl, alkoxy, alkoxyalkyl or acyloxy group each having an asymmetric carbon atom, and R.sub.2 represents a straight-chain alkyl group having an assymmetric carbon.

Abstract: A liquid crystal element has a pair of opposed substrates, electrodes thereon, and a ferroelectric liquid crystal sealed between the substrates. A film of a conductive organic compound or a mixture of a conductive organic compound and another organic compound is disposed on the substrate surface, optionally via an orienting film. The conductive organic compound is typically a charge-transfer complex. The film may be formed by an LB method, coating, vapor phase polymerization or electrolytic polymerization. The element has improved optical bistability, contrast, and response.

Abstract: A benzamide derivative represented by the formula: ##STR1## having a promoting activity of gastrointestinal tract and pharmacentical composition containing the same.

Abstract: An optically active liquid crystal compound which is represented by the formula: ##STR1## wherein R.sub.1 and R.sub.2 each represents an alkyl or aralkyl group of 4-18 carbon atoms, R.sub.3 represents a haloalkyl group, X represents O, COO, OCO, CO or a single bond, Y represents COO, OCO, CH.sub.2 O or OCH.sub.2, Z represents COO or O, (A) represents a cyclic group shown by ##STR2## (B) represents a cyclic group shown by ##STR3## and l shows that the cyclic groups are substituted by at least one halogen atom.

Abstract: Method for the production of asialoganglioside related compounds of the formula (I). ##STR1## wherein R.sup.1 is hydrogen or benzoyl, R.sup.2 is hydrogen or acetyl, R.sup.3 is hydrogen, acetyl, .beta.-D-galactopyranosyl or 2,3,4,6-tetra-O-acetyl-.beta.-D-galactopyranosyl, R.sup.7 and R.sup.8 are individually alkyl having 1 to 30 carbon atoms and Ac is acetyl.

Abstract: This invention relates to new optically active pyrimidinylphenyl ester compounds, having a liquid crystal phase of cholesteric and/or smectic C* phase, of the formula: ##STR1## wherein R* represents an optically-active alkyl group having an asymmetric carbon atom which is ##STR2## where R.sup.0 is a straight chain alkyl group of 2 to 6 carbon atoms, R.sup.1 is a straight chain alkyl group of 1 to 5 carbon atoms, R.sup.2 is a straight chain alkyl group of 1 to 2 carbon atoms, R.sup.3 is a straight chain alkyl group of 1 to 6 carbon atoms and n is 0 or 1, R presents a straight-chain alkyl group of 7 or 8 carbon atoms or a straight-chain alkoxy group of 7 or 8 carbon atoms and A represents ##STR3## or --O--.

Abstract: The present invention is an optically active liquid crystal compound shown in the following general formula; ##STR1## [wherein, A and B respectively show one of --, --O--, ##STR2## (-- shows direct bond), one of R.sub.1 and R.sub.2 shows direct chain alkyl group and the other one shows either alkyl group having asymmetric carbon atom or alkoxy alkyl group having asymmetric carbon atom and ether bonding. Also, onto the asymmetric carbon atom, one of the groups --CH.sub.3, --CN, --Cl is added.]It is clear that there are many compounds in these liquid crystal compounds, that show Sm C* phase in a wide temperature range close to room temperature and that have high response speed.

Abstract: A liquid crystal compound represented by the following general formula:R*O--A--R or R*COO--A--Rwherein R* stands for an alkyl group having an asymmetric carbon atom, R stands for a linear alkyl group, and A stands for ##STR1##

Abstract: A liquid crystal composition comprising at least one optically active liquid crystal compound represented by the following general formula: ##STR1## wherein R.sub.2 stands for a linear alkyl group and R.sub.1 * stands for an alkoxy or acyloxy group having an asymmetric carbon atom,and at least one optically active liquid crystal compound represented by the following general formula: ##STR2## wherein R.sub.3 * stands for an alkyl group having an asymmetric carbon atom and R.sub.4 stands for a linear alkyl group.

Abstract: A liquid crystal compound represented by the following general formula: ##STR1## wherein m is a number from 0 to 10, n is a number from 5 to 14, and C having an asterisk indicates an asymmetric carbon atom.

Abstract: A complex of an acid addition salt of (2'-benzyloxycarbonyl)phenyl trans-4-guanidinomethylcyclohexanecarboxylate and a cyclodextrin. The complex is useful for the treatment of ulcers.

Abstract: A compound of the formula: ##STR1## wherein R.sub.1 represents a vanilyl, napthyl, pyridyl or .alpha.-tocopheryl group, or a group of the formula, ##STR2## wherein R.sub.2 represents a hydrogen atom, a lower alkoxy, formyl, lower alkanoyl or phenyl group, or a group of the formula --(CH.sub.2).sub.n COOR.sub.3, wherein R.sub.3 represents a hydrogen atom, a lower alkyl, phenyl, benzyl, anisyl or lower alkoxycarbonylmethyl group, and n represents an integer of 0 to 2, or a pharmaceutically acceptable salt thereof is effective for use as an anti-ulcer agent.

Abstract: Ureylenethiophanes and their related compounds of the formula: ##SPC1##Having a cis-configuration on the ureylene or thioureylene juncture, which are useful as the intermediates in the synthesis of biologically active biotin and its related compounds, can be produced selectively by reacting the corresponding compounds of the formula: ##SPC2##With isocyanates or isothiocyanates wherein R is a hydrogen atom, an alkyl group or an aralkyl group, R.sub.1 and R.sub.2 are each a hydrogen atom or an aliphatic hydrocarbon group bearing or not a carboxyl group or any other group convertible thereto at the terminal position, X is a halogen atom, Y is an oxygen atom or a sulfur atom and Z is an oxygen atom, a sulfur atom, a sulfinyl group or a sulfonyl group.

Abstract: The dental cement composition comprises an aqueous resin composition prepared by the copolymerization of 3-butene-1,2,3-tricarboxylic acid and an .alpha.,.beta.-olefinic unsaturated monocarboxylic acid and, when desired, an additional polymerizable monomer as well as a metal oxide. The dental cement composition possesses compressive strength.

Abstract: Polyene compounds of the formula: ##EQU1## wherein R' is protected or unprotected hydroxyl or a group of the formula: ##EQU2## (in which R" and R"' are each carboxyl or a group convertible into carboxyl on hydrolysis), m is a positive integer and n is 0 or a positive integer, which are useful as intermediates in the synthesis of coenzyme Q, can be produced advantageously through a step for the dehydration of a compound of the formula: ##EQU3## wherein R', m and n are each as defined above.